INTRODUCTION
Recent progress in understanding the complexity of the human and mouse alkaline phosphatase (AP; EC 3.1.3.1.) gene family and the tissue-specific expression of the individual isoenzyme genes has excited a renewed interest in understanding the biological function of these molecules. APs are membranebound homodimeric glycoenzymes, characteristically dependent on the metal ions zinc and magnesium, that exist in all species from bacteria to man (McComb et al., 1979) . Sequence comparisons (Millan, 1988; Kim and Wyckoff, 1989) between the mammalian APs and the Escherichia coli AP, for which the three-dimensional structure is known (Sowadski et al., 1985) , indicate that they conform to the basic acl/3 architecture of the E. coli enzyme with a highly-conserved central fl-sheet. However, the eukaryotic enzymes possess highly variable loops and major insertions with no equivalents in the E. coli structure (Millan, 1992) . These variable regions are in some instances associated with unique properties of the mammalian APs, such as uncompetitive inhibition (Hummer and Millin, 1991; Hoylaerts and Millkn, 1991; Hoylaerts et al., 1992) and binding to extracellular proteins (Tsonic et al., 1988; Makiya and Stigbrand, 1992) . Because these regions may be responsible for isoenzyme-specific functions, structural-functional relationships based on the E. coli AP structure are not informative in understanding the biological role of mammalian APs, and, consequently, elucidation of the three-dimensional crystallographic structure of at least one mammalian AP is required.
We have chosen the bovine intestinal AP (bIAP) as the model enzyme for the following reasons: (a) purified bIAP is available from a number of manufacturers in large quantities as a reagent with applications in biotechnology, (b) bIAP crystallizes readily and this property can be used as one of the steps in the large-scale ster ovary cells. Recombinant bovine intestinal alkaline phosphatase displays enzymatic properties comparable with those of purified native bovine intestinal alkaline phosphatase, a slightly increased thermal stability and, upon desialylation, it shows a homogeneous behaviour in agarose gel electrophoresis and isoelectric focusing. The availability of the recombinant bovine intestinal alkaline phosphatase and the elucidation of its primary sequence will help to accelerate our efforts to obtain the first crystallographic model of a eukaryotic alkaline phosphatase molecule.
purification of the enzyme, (c) bIAP displays the highest specific activity of any AP known and its structure should provide a reference with which the conformation of specific mutants and catalytically less efficient isoenzymes could be compared. Whilst bIAP was the first mammalian AP for which the sequence surrounding the active site serine was determined (Milstein, 1964) , only very limited protein sequence information (Culp et al., 1985; Besman and Coleman, 1985) is available for bIAP. In this paper we present the cloning of a full-length cDNA and genomic clones for bIAP and we report the entire primary sequence of the enzyme. These data will greatly facilitate our efforts to unravel the three-dimensional structure of bIAP.
MATERIALS AND METHODS Library screening, sequencing and genomic analysis
A AgtlI cDNA library prepared from adult cow intestine (Clontech Laboratories, Palo Alto, CA, U.S.A.) was screened using a 2.2 kb HindlIl fragment containing the 5' end of the mouse IAP gene ) and a 700 bp EcoRI cDNA fragment coding for the C-terminal half of rabbit IAP (unpublished results). The 2.1 kb R201 cDNA clone and the 1.1 kb BB204 cDNA clone isolated from the cow intestinal cDNA library were used to screen an EMBL3 SP6/T7 genomic library prepared from adult cow liver (Clontech Laboratories). Probes were radiolabelled and positive clones were plaque-purified and expanded as described . Large-scale phage DNA preparation was performed as described (Sambrook et al., 1989) . Genomic clones were characterized by Southern blot analysis and sequenced following procedures already described (Marchuk et al., 1990) (Gorman et al., 1982) . A pSV2-dhfr plasmid (Schimke, 1982) was cotransfected to allow selection of transfectants in nucleoside-free medium and possible amplification of the transfected gene upon methotrexate treatment. Stable transfectants were selected as described by Hummer and Millan (1991) . In order to construct a full-length cDNA, reverse transcriptase-PCR (RT-PCR) was performed as follows: total RNA from a bIAP-pcDNA I stablytransfected CHO/cell clone was isolated by acid guanidinium thiocyanate/phenol/chloroform extraction (Chomczynski and Sacchi, 1987 (Hoylaerts et al., 1992 Griffiths and Black (1987) and agarose gel electrophoresis on Paragon gels (Van Hoof et al., 1988 (Culp et al., 1985; Besman and Coleman, 1985) and similarity with the human, rat and mouse IAP sequences (Berger et (Henthorn et al., 1988; Knoll et al., 1988; Milldn and Manes, 1988; Manes et al., 1990) . The exact length of exon XI could not be determined since no cDNA with a poly(A) tail had been isolated. The estimate given is based on the identification of a putative polyadenylation site AATAAA (bp [5183] [5184] [5185] [5186] [5187] [5188] in the 3' non-coding region of the gene (underlined in Figure 2 ). Interestingly, the entire coding region of exon XI shows a high G/C content of over 60-80 % compared with an approximately equal ratio of G/C to A/T throughout the whole structural gene. Other regions of biased nucleotide content were found at bp 270 to bp 490, which shows a high A/T content and in a region preceding the polyadenylation site, which shows a high G/C content. The 1.5 kb sequence preceding the first exon contains the same variant TATA box sequence ATTTAA and the GGGAGGG sequence reported previously in the promoter region ofthe mouse tissue-specific AP (TSAP) genes and two human TSAP genes (Millan, 1987; Millain and Manes, 1988 Manes, 1988) and are thought to form Z-DNA structures of regulatory significance (Nordheim and Rich, 1983) .
The complexity of the bIAP and related genes in the bovine genome is demonstrated in Figure 3 . Two bands in the genomic Southern blot could be identified as fragments derived from the bIAP gene (marked with arrows in Figure 3 ) while one 4.0 kb EcoRI band hybridizes with, and probably corresponds to, the R201 pseudogene. The only other non-human mammalian genome investigated extensively for TSAP genes is the mouse where three loci, embryonic AP (EAP), IAP and a pseudogene have been cloned. There is biochemical evidence of only three AP isoenzymes expressed in cows, a tissue non-specific AP (Garattini et al., 1987) and two tissue-specific APs with differential expression in calf and adult intestine (Besman and Coleman, 1985) . The bIAP gene characterized in this paper codes for the adult bovine intestinal isoenzyme (see below). The identity of the fetal isoenzyme remains to be determined. The expression of two AP isoenzymes in the cow intestine is analogous to the mouse system, where both EAP and IAP mRNA are found in the adult intestine (Hahnel et al., 1990) . Expression of AP in rat intestine seems to be even more complex (Eliakim et al., 1990) with alternatively spliced mRNA being present. Since R201 was cloned from a cDNA library it may represent a transcribed pseudogene or an unusual AP isoenzyme being co-expressed in the adult intestine. Determining whether this gene is equivalent to the EAP isoenzyme in the mouse or is identical to the fetal intestinal AP form described by Besman and Coleman (1985) will require its full characterization.
Deduced amino acid sequence
The deduced amino acid sequence (Figure 4 ) of the bIAP protein is highly homologous to other known IAPs (Berger et al., 1987; Henthorn et al., 1988; Manes et al., 1990; Eliakim et al., 1990) and contains two stretches of amino acids corresponding to the partial peptide sequences previously determined for adult bovine IAP (Culp et al., 1985; Besman and Coleman, 1985) (Figure 4 ; hatched boxes). Conserved residues and/or conservative amino acid substitutions are found within structurally important regions (Figure 4 ; boxed residues), such as the Zn and Mg binding sites and the active site residues Asp-91, Ser-102 and Arg-166. Residue 429, found to play a major role in determining the uncompetitive inhibition properties of human placental and germ cell AP (Hummer and Millain, 1991; Hoylaerts and Millan, 1991; Hoylaerts et al., 1992) , is occupied by Ser in bIAP as in the other known IAPs (Figure 4 , boxed in bold lines). Structural variability is almost exclusively found at the C-terminal end and in the highly variable surface loops (Millan, 1988 (Millan, , 1992 . Asp-487 of bIAP resides within a sequence of 4 amino acids (Figure 4 ; bold italics) conserved between human IAP and human PLAP. The equivalent Asp-484 was shown to be the attachment site of a phosphatidylinositol membrane anchor in PLAP (Micanovic et al., 1988) . Recent evidence (Hoffman-Blume et al., 1991) and results presented below indicate that bIAP is also anchored to the plasma membrane by this mechanism and Asp-487 may serve as the attachment site. Two putative glycosylation sites are conserved between human IAP and bIAP. Three other possible sites found in the other IAP sequences were not found in bIAP (Figure 4 ; shaded residues).
Characterization of the recombinant blAP The cloned bIAP gene was stably transfected and expressed in CHO cells and the extracted recombinant enzyme was compared Figure 4 Comparison of deduced amino acid sequences of blAP, human IAP (hIAP; Henthorn et al., 1988) , mouse IAP (mIAP; Manes et al., 1990 ) and rat IAP (rnAP; Lowe et al., 1990) Residues of blAP that are outlined in hatched lines are identical to sequences obtained by direct protein sequencing (Culp et al., 1985; Besman and Coleman, 1985) . Shaded asparagines represent putative N-linked glycosylation sites. Residues outlined with solid lines are involved in co-ordinating the essential metal ions Zn and Mg and are active site residues (Sowadski et al., 1985) . Residue 429, outlined with bold lines, influences the uncompetitive inhibition properties of APs (Hummer and Millan, 1991; Hoylaerts and Millan, 1991; Hoylaerts et al., 1992 (Figure 5 ). Similarly the recombinant bIAP contains a hydrophobic phosphatidylinositol anchor that is mainly cleaved during extraction at pH 5.5 by endogenous CHO cell-derived phospholipase C. The remaining anchor can be cleaved by adding phosphatidylinositol-specific phospholipase C and phospholipase D ( Figure 5 ). The desialylated, anchorless recombinant bIAP shows a discrete isoelectric focusing pattern compared with the untreated enzyme (data not shown). Industrial bIAP preparations consist mainly of anchorless enzyme containing, however, various degrees of residual sialic acid. This is illustrated in Figure 5 where the BoehringerMannheim preparation is slightly neuraminidase-sensitive in contrast to the Calzyme Laboratories preparation that appears fully desialylated. Both industrial preparations cover a wider range of pl values in isoelectric focusing compared with recombinant bIAP, a behaviour not related to sialic acid content. The heterogeneity observed in different industrial preparations is probably due to the varying degree of autolytic degradative processes occurring in the bovine intestine after slaughtering. This heterogeneity may explain the variability observed in the performance of different batches of commercially available bIAP during different labelling procedures for immunoassays.
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Conclusion
The bIAP sequence presented in this paper and the availability of fully-active recombinant bIAP enzyme with help to solve the three-dimensional crystal structure of the most efficient AP isoenzyme known. This information will be critical in understanding the structural-functional relationship of several AP domains that may be involved in protein-protein interaction and substrate recognition in vivo. In addition, the recombinant bIAP and mutants produced by site-directed mutagenesis may prove of interest for biotechnological applications, since they will provide a source of bIAP of predictable purity and properties.
